Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: probiotics.
- Who it may be relevant to
- Registry conditions: Obesity. Basic parameters: 20 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Probiotics on Regulating Gut Health and Blood Lipid in Overweight and Obese Adults
Overview
The purpose of this study was to evaluate the efficacy of 1 capsules (300 mg per capsule) of Nutrarex Probiotic Capsules per day in regulating gut health and blood lipid in adults by clinical trial.
Detailed description
This experiment is carried out in a controlled manner. Before the subjects enter the research experiment, they need to follow their original lifestyle. The habits of maintaining a constant body weight for more than 2 weeks before the test, such as calorie balance in the diet and the amount of activity. Then enter the test to carry out the evaluation test of probiotics to the end. 50 subjects were randomized, 25 to placebo and 25 to probiotics. The subjects took one capsules of Nutrarex probiotics daily, a total of 300 mg. Continue to take it for 4 weeks, and perform blood routine tests. Body composition detection, waist and hip circumference measurement, related index analysis and 24-hour dietary questionnaires, gut health questionnaires and stool samples were collected and analyzed for 4 weeks before and after treatment.
Interventions
- Dietary supplement probiotics
Eat a capsule for once, and once a day
Primary outcome measures
- Change from baseline serum lipids at week 4 [Time frame: Week0, Week4]
Eligibility criteria
Inclusion criteria
- male or female participants
- aged 20-65 years old
- body mass index in 25-27 kg/m2 or body fat > 25% for men and > 30% for women
Exclusion criteria
- cancer, chronic heart disease, use drugs which pharmacological effects may affect immunity having systemic infections
- using probiotics.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Prevention
Study locations
Taiwan · 1 center
- Chung Shan Medical University — Taichung
Identifiers
NCT: NCT06554314 · CS2-23191